214 related articles for article (PubMed ID: 14692531)
21. The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4.
Ho IC; Hodge MR; Rooney JW; Glimcher LH
Cell; 1996 Jun; 85(7):973-83. PubMed ID: 8674125
[TBL] [Abstract][Full Text] [Related]
22. The cancer germ-line genes MAGE-1, MAGE-3 and PRAME are commonly expressed by human myeloma cells.
Pellat-Deceunynck C; Mellerin MP; Labarrière N; Jego G; Moreau-Aubry A; Harousseau JL; Jotereau F; Bataille R
Eur J Immunol; 2000 Mar; 30(3):803-9. PubMed ID: 10741395
[TBL] [Abstract][Full Text] [Related]
23. High-frequency promoter hypermethylation of the deleted in liver cancer-1 gene in multiple myeloma.
Song YF; Xu R; Zhang XH; Chen BB; Chen Q; Chen YM; Xie Y
J Clin Pathol; 2006 Sep; 59(9):947-51. PubMed ID: 16489177
[TBL] [Abstract][Full Text] [Related]
24. Expression and functional role of c-kit ligand (SCF) in human multiple myeloma cells.
Lemoli RM; Fortuna A; Grande A; Gamberi B; Bonsi L; Fogli M; Amabile M; Cavo M; Ferrari S; Tura S
Br J Haematol; 1994 Dec; 88(4):760-9. PubMed ID: 7529540
[TBL] [Abstract][Full Text] [Related]
25. Limiting dilution cloning of B cells from patients with multiple myeloma: emergence of non-malignant B-cell lines.
Clofent G; Klein B; Commes T; Vincent C; Ghanem N; Lenoir G; Lefranc MP; Bataille R
Int J Cancer; 1989 Apr; 43(4):578-86. PubMed ID: 2539329
[TBL] [Abstract][Full Text] [Related]
26. Identification of primary MAFB target genes in multiple myeloma.
van Stralen E; van de Wetering M; Agnelli L; Neri A; Clevers HC; Bast BJ
Exp Hematol; 2009 Jan; 37(1):78-86. PubMed ID: 19013005
[TBL] [Abstract][Full Text] [Related]
27. The hematopoietic transcription factor PU.1 is downregulated in human multiple myeloma cell lines.
Pettersson M; Sundström C; Nilsson K; Larsson LG
Blood; 1995 Oct; 86(7):2747-53. PubMed ID: 7670114
[TBL] [Abstract][Full Text] [Related]
28. Post-transcriptional Modifications Contribute to the Upregulation of Cyclin D2 in Multiple Myeloma.
Misiewicz-Krzeminska I; Sarasquete ME; Vicente-Dueñas C; Krzeminski P; Wiktorska K; Corchete LA; Quwaider D; Rojas EA; Corral R; Martín AA; Escalante F; Bárez A; García JL; Sánchez-García I; García-Sanz R; San Miguel JF; Gutiérrez NC
Clin Cancer Res; 2016 Jan; 22(1):207-17. PubMed ID: 26341922
[TBL] [Abstract][Full Text] [Related]
29. Chemosensitization of myeloma plasma cells by an antisense-mediated downregulation of Bcl-2 protein.
van de Donk NW; Kamphuis MM; van Dijk M; Borst HP; Bloem AC; Lokhorst HM
Leukemia; 2003 Jan; 17(1):211-9. PubMed ID: 12529680
[TBL] [Abstract][Full Text] [Related]
30. Quantitation of multiple myeloma oncogene 1/interferon-regulatory factor 4 gene expression in malignant B-cell proliferations and normal leukocytes.
Yamada M; Asanuma K; Kobayashi D; Moriai R; Yajima T; Yagihashi A; Yamamori S; Watanabe N
Anticancer Res; 2001; 21(1B):633-8. PubMed ID: 11299818
[TBL] [Abstract][Full Text] [Related]
31. CD221 (IGF-1R) is aberrantly expressed in multiple myeloma, in relation to disease severity.
Bataille R; Robillard N; Avet-Loiseau H; Harousseau JL; Moreau P
Haematologica; 2005 May; 90(5):706-7. PubMed ID: 15921396
[TBL] [Abstract][Full Text] [Related]
32. Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage.
Rawstron AC; Owen RG; Davies FE; Johnson RJ; Jones RA; Richards SJ; Evans PA; Child JA; Smith GM; Jack AS; Morgan GJ
Br J Haematol; 1997 Apr; 97(1):46-55. PubMed ID: 9136941
[TBL] [Abstract][Full Text] [Related]
33. Expression of the bcl-2 gene in human multiple myeloma cell lines and normal plasma cells.
Pettersson M; Jernberg-Wiklund H; Larsson LG; Sundström C; Givol I; Tsujimoto Y; Nilsson K
Blood; 1992 Jan; 79(2):495-502. PubMed ID: 1730093
[TBL] [Abstract][Full Text] [Related]
34. Normal and neoplastic human plasma cells express bcl-2 antigen.
Hamilton MS; Barker HF; Ball J; Drew M; Abbot SD; Franklin IM
Leukemia; 1991 Sep; 5(9):768-71. PubMed ID: 1943229
[TBL] [Abstract][Full Text] [Related]
35. Expression of transcription factors Pu.1, Spi-B, Blimp-1, BSAP and oct-2 in normal human plasma cells and in multiple myeloma cells.
Nagy M; Chapuis B; Matthes T
Br J Haematol; 2002 Feb; 116(2):429-35. PubMed ID: 11841448
[TBL] [Abstract][Full Text] [Related]
36. Human bone marrow stroma-dependent cell line MOLP-5 derived from a patient in leukaemic phase of multiple myeloma.
Matsuo Y; Drexler HG; Nishizaki C; Harashima A; Fukuda S; Kozuka T; Sezaki T; Orita K
Br J Haematol; 2000 Apr; 109(1):54-63. PubMed ID: 10848782
[TBL] [Abstract][Full Text] [Related]
37. Neoplastic plasma cell aberrant antigen expression patterns and their association with genetic abnormalities.
Salama ME; Du S; Efimova O; Heikal NM; Wendlandt E; Toydemir RM; South S; Perkins SL; Hussong JW; Zhan F
Leuk Lymphoma; 2015 Feb; 56(2):426-33. PubMed ID: 24913506
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-6 gene expression in multiple myeloma: a characteristic of immature tumor cells.
Hata H; Xiao H; Petrucci MT; Woodliff J; Chang R; Epstein J
Blood; 1993 Jun; 81(12):3357-64. PubMed ID: 8507873
[TBL] [Abstract][Full Text] [Related]
39. Establishment of CD7+ human myeloma sister cell lines, KMS-21-PE and KMS-21-BM, carrying t(11;14) and t(8;14).
Otsuki T; Wada H; Nakazawa N; Taniwaki M; Kouguchi K; Ohkura M; Uehira K; Isoda K; Yata K; Sakaguchi H; Yawata Y; Ueki A; Yamada O
Leuk Lymphoma; 2001 Aug; 42(4):761-74. PubMed ID: 11697507
[TBL] [Abstract][Full Text] [Related]
40. Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1.
Jourdan M; De Vos J; Mechti N; Klein B
Cell Death Differ; 2000 Dec; 7(12):1244-52. PubMed ID: 11175262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]